PRESS RELEASE: BIGBEN: Strong increase of FY 2020/21 Annual Results


Bigben                                                Press release

           Lesquin, 31 May 2021 18:00hrs

Strong increase of FY 2020/21 Annual Results

  • Sales:292.8 M€ (+11.1%)
  • Current Operating Income:36.2 M€ (+52.9%), i.e.12.4% of sales

Proposal for a 0.30 € dividend

Targets for FY 2021/2022:

  • Sales between300 and 320 M€
  • CurrentOperating Margin(1)of 13%

Upward revisionof FY 2022/2targets:

  • Sales between360 and 390 M€
  • Current Operating Margin(1) > 14%

BIGBEN INTERACTIVE (ISIN FR0000074072) today releases its audited consolidated results for FY 2020/21 (from April 1, 2020 to March 31, 2021) as approved by its Board of directors on 31 May 2021.

Consolidated in M€ - IFRS2020/212019/20Change
Gross margin (2)
In % of Sales

In % of Sales






Current operating income
In % of Sales

Non-recurring items





Operating result
In % of Sales
Financial result
Including currency gain (loss)

Earnings before tax
In % of Sales

Net result for the period
In % of Sales


(1)   COM = Current Operating Margin = COI Rate = Current Operating Incomeas a percentage of sales

(2)   Gross Margin = Sales - Cost of goods sold; other Operating revenues are posted between Gross Margin and EBITDA

(3)   EBITDA = Current Operating Income before depreciation and amortization of tangible and intangible assets

52.9% increase in current operating profitability

BIGBEN achieved an 11.1% increase in sales to 292.8 M€ in FY 2020/21, exceeding the 290 M€ upper end of the sales target range. This growth was driven by the performance of Nacon Gaming, while Bigben Audio/Telco demonstrated its resilience by limiting its decline in business and optimising its margins.

The gross margin rate increased to 41.6%, thanks to Nacon's achievements and to an Audio/Telco product mix more favourable to premium brands.

Current Operating Income jumped by 52.9% to 36.2 M€ i.e. a COI rate of 12.4% of sales.

After taking into account 6.4 M€ non-recurring expenses relating to bonus share plans, a 2.7 M€ net financial charge and 8.2 M€ income tax, Net Profit for the period was up 16.4% to 18.9 M€, or 0.95€ per share (compared to 0.82€ at 31 March 2020) (4).

(4)   Based on the number of shares at 31 March 2021 and 31 March 2020

Analysis of acheviements by business units

Consolidated in M€ - IFRS2020/212019/20(5)   Change2020/212019/20Change.
Gross Margin(2)93.579.1+18.3%28.329.9-5.1%
In % of Sales52.6%61.1%24.6%22.3%
EBITDA (3)60.348.4+24.7%7.34.1+76.4%
In % of Sales33.9%37.4%6.3%3.1%
Current Operating Income32.522.6+43.8%3.71.1+245.2%
In % ofSales18.3%17.5%3.2%0.8%

(5)   Nacon was created in July 2019 and started its activity in October 2019 following the partial contribution of assets of the Gaming business to Nacon by Bigben Interactive. The contributed assets and liabilities were recognised at their book value. Nacon's consolidated financial statements as at March 31, 2020 were made up of six months of "combined financial statements" for the Gaming business prepared from the accounting records of Bigben Interactive and its Gaming subsidiaries covering the period from April 2019 to September 2019, to which were added the flows and items of the new entity covering the period from October 2019 to March 2020

In FY 2020/21, Nacon Gaming posted sales of 177.8 M€, an increase of 37.4% driven by the tripling of back catalogue sales (31.0 M€), the success of premium accessories and the successful implantation in the USA of RIG® headsets.

The lockdown sequences had a strong impact on the distribution networks of Bigben Audio/Telco which demonstrated its resilience by limiting the drop in sales to 115.0 M€ i.e. -14.2% and by returning to growth (+5.2% in sales) in the 4th quarter of FY 2020/21. An Audio/Telco product mix geared toward premium brands allowed to improve the gross margin to 24.6% of sales (compared with 22.3% at 31 March 2020). Thanks to an 18.2% reduction in external costs, EBITDA increased by 76.4% to 7.3 M€ tripling Current Operating Income to 3.7 M€.

Robust balance sheet structure with 177.8 M€ cash available

At 31 March 2021, BIGBEN showed a robust balance sheet structure with shareholders' equity increasing to 302.0 M€.

Cash available increased by 59.7 M€ to 177.8 M€ thanks in particular to the 87.3 M€ funds raised through the February 2021 issue of Bigben bonds exchangeable for Nacon shares.

On the other hand, debts which include the entire bond issue amounted to 145.6 M€, generating a positive net cash position of 32.2 M€.

2021/22 outlook driven by the growth of Nacon

The positive trend in the Gaming business has led Nacon to bring forward its FY 2022/23 targets to FY 2021/22 (6). This favourable development allows BIGBEN to announce a sales target of between 300 and 320 M€ for the current FY 2021/22, with a Current Operating Margin (1) of 13%.

In order to achieve its targets, Nacon Gaming will rely on

  • the ongoing digital sales of the back catalogue;
  • the launch of new video games;
  • the commercial momentum of accessories, which will benefit in particular from the release of the Revolution X Pro controller for Xbox®.

In addition, the BIGBEN Group intends to confirm the return to growth of Bigben Audio/Telco thanks to:

  • a market driven towards the high-end with the gradual deployment of the 5G network,
  • the conquest of new sales channels for mobiles,
  • the expansion of the Just Green® and Force® mobile accessory ranges as well as the launch of new Audio products.

Upward revision of 2022/23 annual targets

Thanks to the prospects of Nacon Gaming which has raised its FY 2022/23 (6) targets, the BIGBEN Group is raising the targets of its "BIGBEN 2023" plan, with, for FY 2022/23 :

  • sales between 360 and 390 M€ (compared to a 350 M€ initial forecast),
  • a Current Operating Margin (1) in excess of 14% (compared to 13% previously).

Dividend 2021

In view of the quality of the financial results for FY 2020/21 and the confidence in the outlook, Bigben Interactive's Board of Directors meeting on 31 May 2021, decided to submit a 0.30€ dividend per share for FY 2020/21 to the vote of the Annual General Meeting to be held on 30 July 2021.

Share buybacks

The company intends to continue to buy back its shares in FY 2021/22.

(6)   Nacon press release of 31 May 2021

Upcoming events:

Annual General Meeting: Friday 30 July 2021

Q1 2021/22 sales: Monday 26 July 2021, Press release after close of the Euronext Paris stock exchange


SALES 2020-21
292.8 M€

Ca. 920 employees

23 subsidiaries and a distribution network in 100 countries

Bigben Interactive is a European player in video game development and publishing, in design and distribution of smartphone and gaming accessories as well as in audio products. The Group, which is recognized for its capacities in terms of innovation and creativity, intends to become one of Europe’s leaders in each of its markets

Company listed on Euronext Paris, compartment B – Index : CAC Mid & Small – Eligible SRD long
ISN : FR0000074072 ; Reuters : BIGPA ; Bloomberg : BIGFP


CapValue – Gilles Broquelet - +33 1 80 81 50 01 


To view this piece of content from, please give your consent at the top of this page.
To view this piece of content from, please give your consent at the top of this page.

About GlobeNewswire

One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Data analysis from dLab to boost the digitalization for Karlskoga Energi & Miljö24.6.2021 09:55:00 CEST | Press release

Regional utilities company Karlskoga Energi & Miljö AB has been using the smart data analytics solution from cleantech company Dlaboratory Sweden AB (publ) since 2020. A useful solution for avoiding power outages and identifying faults, dLab’s system is the starting point for the energy company’s digitalization journey. Energy company Karlskoga Energi & Miljö with its subsidiary Karlskoga Elnät has around 15 000 customers along a 1 700 km grid in the middle of the beautiful region of Värmland. Digitalization is a high priority throughout the organization, whether it means providing fiber optics for consumers, or the dInsight Analytics Platform from dLab. -The solution from dLab pushes us to work in a completely new way; from monitoring and analysis to becoming proactive, using data to prevent, rather than fix a problem. This requires new knowledge in the organization, but also a new way of working, says Jimmy Lundberg, Head of Distribution at Karlskoga Elnät. The company chose dLab’s s

Nokia launches next-generation AirScale 5G portfolio powered by ReefShark technology24.6.2021 09:00:00 CEST | Press release

Press Release Nokia launches next-generation AirScale 5G portfolio powered by ReefShark technology Nokia’s new, industry-leading 5G portfolio covers baseband, radio, and massive MIMO antennas offering huge 5G capacity, coverage, and easy deploymentIntroduces industry’s lightest massive MIMO units at 17kg enabling simplified deployments and faster time to marketNokia’s new comprehensive range of products are powered by Nokia’s latest generation of ReefShark chipsets Nokia’s extended Single RAN accelerates 5G rollouts and cuts overall RAN Total Cost of Ownership 24 June 2021 Espoo, Finland – Nokia today announced the global launch of its latest range of industry-leading AirScale 5G products covering baseband, remote radio heads, and massive MIMO active antennas with digital beamforming. The innovative solutions are powered by the latest generation of Nokia’s ReefShark System-on-Chip (SoC) chipsets and deliver the highest capacity and network performance while enabling efficient deploymen

Huvepharma Announces the Indicative Price Range, Publication of the Prospectus and Start of the Offer Period of Planned IPO24.6.2021 08:15:39 CEST | Press release

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. This announcement is an advertisement for the purposes of the Prospectus Regulation EU 2017/1129 and underlying legislation, relating to the launch of the Offer (as defined below) by the Company and the proposed Admission (as defined below). This announcement does not constitute a prospectus. This announcement is for information purposes only and is not intended to constitute, and should not be construed as, an offer to sell or a solicitation of any offer to buy Shares (as defined below) in any jurisdiction, including the United States, Canada, Australia or Japan. Further details about the Offer and the Admission is included in the Prospectus (as defined below). The Prospectus has today been approved by the Netherlands Authority for the Financial Markets (Stich

FDA accepts application for Roche’s Port Delivery System with ranibizumab (PDS) for treatment of neovascular or “wet” age-related macular degeneration (nAMD)24.6.2021 07:00:00 CEST | Press release

If approved, PDS would be the first and only eye implant with continuous drug delivery that offers people living with nAMD an alternative to frequent eye injectionsA pivotal study showed PDS extends time between treatments up to six months for more than 98% of patients and provides vision outcomes equivalent to monthly ranibizumab injectionsThe European Medicines Agency has also validated the PDS Marketing Authorisation Application in nAMD Basel, 24 June 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Biologics License Application (BLA), under Priority Review, for Port Delivery System with ranibizumab (PDS) for the treatment of neovascular or “wet” age-related macular degeneration (nAMD). Neovascular AMD is a leading cause of blindness for people aged 60 and over and impacts approximately 20 million people worldwide.1,2,3 If approved, PDS would be a first-of-its-kind therapeutic approach, offering pe

ObsEva To Present Data on Two Clinical Development Programs at ESHRE Virtual 37th Annual Meeting24.6.2021 07:00:00 CEST | Press release

- Data from Phase 3 study ofYselty® (linzagolix) for the treatment of uterine fibroids to be discussed in an oral presentation; Top-line data from pilot study of Yselty for the treatment of severe adenomyosis to be presented in an ePoster- -Data from IMPLANT1 Phase 2 study of nolasiban for uterine contractility of IVF patients prior to embryo transfer to be presented in an ePoster - GENEVA, Switzerland and BOSTON– June 24, 2021 – ObsEva SA (NASDAQ: OBSV) (SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today announced the presentation of data from two of its clinical development programs at the European Society of Human Reproduction and Embryology (ESHRE) Virtual 37th Annual Meeting, being held June 26 - July 1, 2021. Details of the presentations for the Yseltyprogram are as follows: Title: Long-Term Secondary Efficacy of Linzagolix for Heavy Menstrual Bleeding (HMB) Due to Uterine Fibroids (UF): 52-Week Res

Hyloris Successfully Renegotiates License Agreements for Lead Products with the Alter Pharma Group24.6.2021 07:00:00 CEST | Press release

Acquires all royalty rights to Maxigesic® IV Assumes sole responsibility for HY-075 and HY-038 – future profit split lapses Gains higher net profit margin for Fusidic Acid Cream in Canada Hyloris CEO and CBDO to resign from the Board of Directors of Alter Pharma Liège, Belgium – 24June 2021 – Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), a specialty biopharma company committed to bringing innovative treatments that offer added value to underserved patient populations, today announces that it has successfully renegotiated and unwound its earlier license agreements with the Alter Pharma Group. Hyloris will pay the Alter Pharma Group a total lump sum of €5.25 million plus €0.5 million potential earn-out, thereby waiving any further future financial obligations towards the Alter Pharma Group. Hyloris Pharmaceuticals and the Alter Pharma Group have amended and unwound the earlier license agreements as follows: The patent and knowhow license agreement in relation to Maxigesic IV has b

Enento Group makes a strategic investment to add a unique Sales Intelligence service offering by acquiring a part of Goava Sales Intelligence AB with possibility to take majority24.6.2021 07:00:00 CEST | Press release

ENENTO GROUP PLC, STOCK EXCHANGE RELEASE ON 24 JUNE 2021 AT 8.00 A.M. EEST Enento Groupmakes a strategic investment to add a uniqueSales Intelligence service offering byacquiring apart of Goava Sales Intelligence AB with possibility to take majority Enento Group Plc has signed an agreement to acquire part of and become the largest shareholder of the Swedish sales intelligence services company Goava Sales Intelligence AB by subscribing to new preference shares in the company. Within the agreement, Enento in the first stage on 24 June 2021 acquires a 38,3 % (35,1 % fully diluted) shareholding in the company, and at the same time agrees to complete subsequent preference share subscriptions provided that the company fulfills certain preconditions laid out in the business plan, as well as acquires a purchase option to acquire all outstanding shares in the company after a mutually agreed business plan period ending in year 2024 and aiming at gaining a significant market position for the serv